当前位置:
X-MOL 学术
›
Cancer Cell
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Mastering the Complex Targeted Therapy for Non-small Cell Lung Cancer.
Cancer Cell ( IF 50.3 ) Pub Date : 2020-08-27 , DOI: 10.1016/j.ccell.2020.07.011 Siddhartha Devarakonda 1 , Ramaswamy Govindan 1 , Daniel Morgensztern 1
中文翻译:
掌握非小细胞肺癌的复杂靶向治疗。
更新日期:2020-09-14
Cancer Cell ( IF 50.3 ) Pub Date : 2020-08-27 , DOI: 10.1016/j.ccell.2020.07.011 Siddhartha Devarakonda 1 , Ramaswamy Govindan 1 , Daniel Morgensztern 1
Affiliation
In a recent Nature article, Middleton et al. report the National Lung Matrix trial results where patients with previously treated non-small cell lung cancer (NSCLC) are assigned to personalized therapy based on the results of a 28-gene next-generation sequencing panel test.
中文翻译:
掌握非小细胞肺癌的复杂靶向治疗。
在最近的《自然》杂志上,Middleton等人。报告了国家肺部矩阵试验的结果,其中基于28基因下一代测序专家组测试的结果,将先前接受过治疗的非小细胞肺癌(NSCLC)患者分配到个性化治疗中。